RESUMEN
The Intergovernmental Negotiating Committee on Plastic Pollution seeks to address, among other issues, the science-policy interface of plastic pollution in the forthcoming international legally binding instrument on plastic pollution, including in the marine environment (ILBI) to be finalised in 2024 by the United Nations Environment Assembly (UNEA). Given the importance of protecting the marine environment from plastic pollution, this paper reviews ILBI and argues that the UNEA should by Resolution establish an independent scientific committee. The committee should have an overarching global, regional, and local presence with institutional openness and accessibility to elucidate the science behind plastic pollution. This paper proposes that an independent scientific approach is preferrable to a combined science-policy institution seen in Secretariats and Conference of Parties in some conventions. The latter often exhibit numerous weaknesses. Establishing an independent scientific committee will ensure the science behind plastic pollution is robust, credible, and effectively informs policy decisions.
Asunto(s)
Política Ambiental , Plásticos , Naciones Unidas , Plásticos/análisis , Contaminación Ambiental , Monitoreo del AmbienteRESUMEN
Background and Objectives: Pre-clinical studies have demonstrated direct influences of the sympathetic and vagal/parasympathetic branches of the autonomic nervous system (ANS) on the immune system. The relevance of these pathways to the development of inflammatory disorders in humans remains unknown. We hypothesized that a comprehensive examination of the ANS-immune network in patients with HIV, would reveal that the type and severity of autonomic neuropathy (AN) would predict immune phenotypes with distinct clinical and demographic characteristics. Methods: This is a cross-sectional study of 79 adult people with a history of well-controlled HIV on stable combination antiretroviral treatment (CART) recruited from a primary care clinic network within the Mount Sinai Health System in New York City. All participants underwent a standardized battery of autonomic function tests summarized as the Composite Autonomic Severity Score (CASS) and vagal and adrenergic baroreflex sensitivity (BRS-V and BRS-A). Immune profiling included: 1) measurement of interleukin-6 (IL-6) as part of the Olink assay Target 96 Inflammation Panel, 2) non-negative matrix factorization (NMF) clustering analyses on Olink immune biomarkers, and 3) mass cytometry (CyTOF) on a subset of participants with and without autonomic neuropathy (N = 10). Results: Reduced activity of caudal vagal circuitry involved in the cholinergic anti-inflammatory pathway (CAP) predicted higher levels of IL-6 (Spearman's rho = -0.352, p=0.002). The comprehensive assessment of the ANS-immune network showed four immunotypes defined by NMF analyses. A pro-inflammatory immunotype defined by elevations in type 1 cytokines (IL-6, IL-17) and increased numbers of CD8+ T-cells was associated with autonomic neuropathy (AN). This association was driven by deficits in the cardiovascular sympathetic nervous system and remained strongly significant after controlling for the older age and greater burden of co-morbid illness among participants with this immunotype (aOR=4.7, p=0.017). Discussion: Our results provide novel support for the clinical relevance of the CAP in patients with chronic inflammatory AN. These data also provide insight regarding the role of the sympathetic nervous system and aging in the progression and development of co-morbidities in patients with chronic HIV and support future research aimed at developing therapies focused on modulation of the sympathetic and parasympathetic/vagal nervous system.
RESUMEN
Despite significant and coordinated efforts to combat schistosomiasis, such as providing clean water, sanitation, hygiene, and snail control, these strategies still fall short, as regions previously thought to be disease-free have shown active schistosomiasis transmission. Therefore, it is necessary to implement integrated control methods, emphasizing vaccine development for sustainable control of schistosomiasis. Vaccination has significantly contributed to global healthcare and has been the most economically friendly method for avoiding pathogenic infections. Over the years, different vaccine candidates for schistosomiasis have been investigated with varying degrees of success in clinical trials with many not proceeding past the early clinical phase. Recently, proteins have been mentioned as targets for drug discovery and vaccine development, especially those with multiple functions in schistosomes. Moonlighting proteins are a class of proteins that can perform several functions besides their known functions. This multifunctional property is believed to have been expressed through evolution, where the polypeptide chain gained the ability to perform other tasks without undergoing any structural changes. Since proteins have gained more traction as drug targets, multifunctional proteins have thus become attractive for discovering and developing novel drugs since the drug can target more than one function. Moonlighting proteins are promising drug and vaccine candidates for diseases such as schistosomiasis, since they aid in disease promotion in the human host. This manuscript elucidates vital moonlighting proteins used by schistosomes to drive their life cycle and to ensure their survival in the human host, which can be used to develop anti-schistosomal therapeutics and vaccinomics.
RESUMEN
The anti-viral drug hydroxychloroquine (HCQ) has captivated significant interest in the pharmaceutical field, as it is a quinolone derivative. Its unrestrained occurrence causes prominent health hazards owing to its persistent, carcinogenic, recalcitrant, and teratogenic nature. Herein, in this work, an experimental investigation was carried out toward the photocatalytic degradation of HCQ drug using magnesium zirconate (MgZrO3) nanoparticles as an effective photocatalyst. A comprehensive characterizations of the as-synthesized material was carried out. The photocatalytic degradation of the HCQ drug was examined with various sources of light energies. The obtained outcomes indicated that ±85% of HCQ was degraded using a MgZrO3 photocatalyst within 30 min of the reaction time under UV-visible (ultraviolet) light irradiation. Further, other significant operational parameters such as various catalyst dosages, HCQ concentrations, pH, scavengers, and salts were examined. The degradation studies revealed that the reaction followed pseudo-first-order kinetics. Hence, this perovskite-type MgZrO3 has grasped profound attention in environmental remediation, significantly in photocatalytic degradation of HCQ drug. This comprehensive research offers green synthesis strategy as a substantial framework for providing effective photocatalyst that addresses contemporary water pollution issues linked to notable results. This aids in targeting era-driven advancements toward a clean and safe future environment.
Asunto(s)
Antivirales , Nanopartículas , Circonio , Catálisis , Circonio/química , Antivirales/química , Antivirales/síntesis química , Antivirales/farmacología , Nanopartículas/química , Magnesio/química , Solventes/química , Procesos Fotoquímicos , Estructura MolecularRESUMEN
Introduction: Gastrointestinal dysfunction, including microbiome changes and increased translocation across a compromised gastrointestinal barrier plays a role in the chronic inflammation experienced by people with HIV (PWH). It is unknown whether autonomic neuropathy (AN) may contribute to these mechanisms by altering gastrointestinal motility. Methods: This is a cross-sectional study of 100 PWH and 89 controls. All participants underwent assessment of gastrointestinal transit times using a wireless motility capsule (WMC). All PWH and a subset of controls also underwent: a standardized battery of autonomic function tests summarized as the Modified Composite Autonomic Severity Score (MCASS) and its adrenergic, cardiovagal and sudomotor sub-scores, breath testing for small intestinal bacterial overgrowth (SIBO), and the Patient Assessment of Upper Gastrointestinal Disorders Symptoms (PAGI-SYM) and Composite Autonomic Symptom Score 31 (COMPASS-31) questionnaires. Results: PWH displayed shorter gastric emptying times (GET) and longer small bowel and colonic transit times (SBTT, CTT) compared to controls. Among PWH, GET was associated with PAGI-SYM score. The MCASS and its sudomotor sub-score (reflecting peripheral sympathetic function) were associated with SBTT but not GET or CTT. PWH with prolonged SBTT (>6h) were more likely to have SIBO. Conclusion: Gastrointestinal motility is altered in PWH. This study provides preliminary evidence that changes in autonomic function may influence SBTT in PWH and that prolonged SBTT may contribute to the development of SIBO. Future studies are needed to more fully elucidate the pathophysiologic links between HIV-associated AN, altered gastrointestinal motility, the gastrointestinal microbiome, chronic inflammation, and resulting morbidity and mortality among PWH.
RESUMEN
Aim: The epigenome influences gene regulation and phenotypes in response to exposures. Epigenome assessment can determine exposure history aiding in diagnosis.Materials & methods: Here we developed and implemented a machine learning algorithm, the exposure signature discovery algorithm (ESDA), to identify the most important features present in multiple epigenomic and transcriptomic datasets to produce an integrated exposure signature (ES).Results: Signatures were developed for seven exposures including Staphylococcus aureus, human immunodeficiency virus, SARS-CoV-2, influenza A (H3N2) virus and Bacillus anthracis vaccinations. ESs differed in the assays and features selected and predictive value.Conclusion: Integrated ESs can potentially be utilized for diagnosis or forensic attribution. The ESDA identifies the most distinguishing features enabling diagnostic panel development for future precision health deployment.
This article introduces ESDA, a new analytic tool for integrating multiple data types to identify the most distinguishing features following an exposure. Using the ESDA, we were able to identify signatures of infectious diseases. The results of the study indicate that integration of multiple types of large datasets can be used to identify distinguishing features for infectious diseases. Understanding the changes from different exposures will enable development of diagnostic tests for infectious diseases that target responses from the patient. Using the ESDA, we will be able to build a database of human response signatures to different infections and simplify diagnostic testing in the future.
Asunto(s)
COVID-19 , Epigenómica , Aprendizaje Automático , Staphylococcus aureus , Humanos , Epigenómica/métodos , Staphylococcus aureus/genética , COVID-19/virología , COVID-19/genética , SARS-CoV-2/genética , Epigenoma , Subtipo H3N2 del Virus de la Influenza A/genética , Bacillus anthracis/genética , Algoritmos , Epigénesis Genética , Transcriptoma , Infecciones por VIH/genética , Gripe Humana/genéticaRESUMEN
Food additives enhance sensory pleasure and improve marketability in food product formulations, yet their potential health risks are highly consequential. Tertiary butylhydroquinone (TBHQ), in this regard, has a controversial reputation owing to its neurotoxic effects, which include convulsions and other chronic issues. This situation underscores the need for an advanced electrochemical sensing platform. The current study advocates the utilization of copper tungstate nanoparticles to enhance the sensitivity, selectivity, and efficiency in TBHQ detection, thus addressing the challenges posed by the excessive use of additives and safeguarding the integrity of the food supply chain. Hydrothermally synthesized CuWO4 nanoparticles exhibited superior physicochemical and morphological characteristics, bringing about wide linear response ranges (0.01 to 789 µM), high selectivity, excellent anti-interference capabilities, and a low detection limit of 0.9 nM (S/N = 3). The CuWO4 modified screen printed carbon electrode (SPCE) presents promising recovery ranges in food samples, facilitating real-time monitoring and streamlining the quality assessment of food additives.
RESUMEN
Background: Musician's focal task-specific dystonia is a complex disorder of fine motor control, with incomplete understanding of its etiology. There have been relatively few trials of botulinum toxin in upper limb task-specific dystonia, and prior studies have yielded variable results, leading to skepticism regarding the utility of this approach in elite performers. Methods: We conducted a double-blind, placebo-controlled, randomized, cross-over study of incobotulinum toxin-A in 21 professional musicians with focal upper extremity task-specific dystonia affecting performance on their instrument, using a novel paradigm of initial injections followed by booster injections at two- and four-week intervals. The primary outcome measure was the change in blinded dystonia rating of the active arm by two expert raters using a Clinical Global Impression numeric scale at week 8 compared to enrollment. Findings: 19 men and 2 women with musicians' dystonia were enrolled over a six-year period. Nineteen patients completed the study. Analysis of the primary outcome measure in comparison to baseline revealed a change in dystonia severity of P = 0.04 and an improvement in overall musical performance of P = 0.027. No clinically significant weakness was observed, and neutralizing antibodies to toxin were not found. Interpretation: Despite its small sample size, our study demonstrated a statistically significant benefit of incobotulinum toxin-A injections as a treatment for musicians' task-specific dystonia. Tailoring the use of toxin with booster injections allowed refinement of dosing strategy and outcomes, with benefits that were meaningful to patients clearly visible on videotaped evaluations. In addition to its application to musicians' dystonia, this approach may have relevance to optimize application of botulinum toxin in other forms of focal dystonia such as blepharospasm, cervical dystonia, writer's cramp, and spasmodic dysphonia.
Asunto(s)
Toxinas Botulínicas Tipo A , Estudios Cruzados , Trastornos Distónicos , Música , Fármacos Neuromusculares , Humanos , Método Doble Ciego , Masculino , Femenino , Toxinas Botulínicas Tipo A/administración & dosificación , Trastornos Distónicos/tratamiento farmacológico , Trastornos Distónicos/fisiopatología , Adulto , Fármacos Neuromusculares/administración & dosificación , Fármacos Neuromusculares/farmacología , Persona de Mediana Edad , Resultado del Tratamiento , Enfermedades Profesionales/tratamiento farmacológicoRESUMEN
The Global Task Force on Chronic Pain in HIV published seven research priorities in the field of HIV-associated chronic pain in 2019: (1) causes; (2) management; (3) treatment individualization and integration with addiction treatment; (4) mental and social health factors; (5) prevalence; (6) treatment cost effectiveness; and (7) prevention. The current study used a web-based survey to determine whether the research topics were aligned with the priorities of adults with lived experiences of HIV and chronic pain. We also collected information about respondents' own pain and treatment experiences. We received 311 survey responses from mostly US-based respondents. Most respondents reported longstanding, moderate to severe, multisite pain, commonly accompanied by symptoms of anxiety and/or depression. The median number of pain treatments tried was 10 (IQR = 8, 13), with medications and exercise being the most common modalities, and opioids being viewed as the most helpful. Over 80% of respondents considered all research topics either "extremely important" or "very important". Research topic #2, which focused on optimizing management of pain in people with HIV, was accorded the greatest importance by respondents. These findings suggest good alignment between the priorities of researchers and US-based people with lived experience of HIV-associated chronic pain.
RESUMEN
BACKGROUND AND PURPOSE: To understand the association of sex-specific race and ethnicity on the short-term outcomes of initial and recurrent ischemic stroke events. METHODS: Using the Paul Coverdell National Acute Stroke Program from 2016-2020, we examined 426,062 ischemic stroke admissions from 629 hospitals limited to non-Hispanic White (NHW), non-Hispanic Black (NHB), and Hispanic patients. We performed multivariate logistic regression analyses to assess the combined effects of sex-specific race and ethnicity on short-term outcomes for acute ischemic stroke patients presenting with initial or recurrent stroke events. Outcomes assessed include rates of in-hospital death, discharge to home, and symptomatic intracranial hemorrhage (sICH) after reperfusion treatment. RESULTS: Among studied patients, the likelihood of developing sICH after reperfusion treatment for initial ischemic stroke was not significantly different. The likelihood of experiencing in-hospital death among patients presenting with initial stroke was notably higher among NHW males (AOR 1.59 [95 % CI 1.46, 1.73]), NHW females (AOR 1.34 [95 % CI 1.23, 1.45]), and Hispanic males (AOR 1.57 [95 % CI 1.36, 1.81]) when compared to NHB females. Hispanic females were more likely to be discharged home when compared to NHB females after initial stroke event (AOR 1.32 [95 % CI 1.23, 1.41]). NHB males (AOR 0.90 [95 % CI 0.87, 0.94]) and NHW females (AOR 0.89 [95 % CI 0.86, 0.92]) were less likely to be discharged to home. All groups with recurrent ischemic strokes experienced higher likelihood of in-hospital death when compared to NHB females with the highest likelihood among NHW males (AOR 2.13 [95 % CI 1.87, 2.43]). Hispanic females had a higher likelihood of discharging home when compared to NHB females hospitalized for recurrent ischemic stroke, while NHB males and NHW females with recurrent ischemic stroke hospitalizations were less likely to discharge home. CONCLUSIONS: Sex-specific race and ethnic disparities remain for short-term outcomes in both initial and recurrent ischemic stroke hospitalizations. Further studies are needed to address disparities among recurrent ischemic stroke hospitalizations.
Asunto(s)
Accidente Cerebrovascular Isquémico , Accidente Cerebrovascular , Femenino , Humanos , Masculino , Negro o Afroamericano , Mortalidad Hospitalaria , Accidente Cerebrovascular Isquémico/diagnóstico , Accidente Cerebrovascular Isquémico/terapia , Accidente Cerebrovascular/diagnóstico , Accidente Cerebrovascular/terapia , Población Blanca , Blanco , Hispánicos o LatinosRESUMEN
Despite their diverse application profile, aromatic organochlorides such as 2,4,6-trichlorophenol (TP) are widely renowned for creating a negative toll on the balance of the ecosystem. Strict regulatory regimes are required to limit exposure to such organic pollutants. By deployment of a straightforward detection scheme, electrochemical sensing technology offers a competitive edge over the other techniques and practices available for pollutant monitoring. Here, we present a streamlined hydrothermal approach for synthesizing copper-manganese layered double hydroxide (CuMn-LDH) rods to be employed as electrocatalysts for detecting TP in various media. With a focused intention to leverage the full potential of the prepared CuMn-LDHs, the interlamellar region is configured using a series of intercalants. Further, a thorough comparative analysis of their structures, morphologies, and electrochemical performance is accomplished using various analytical techniques. The electrocatalytic oxidation ability of the CuMn-LDH toward TP molecules is markedly altered by incorporating various anions into the gallery region. The dynamic attributes of the developed sensor, such as a wide linear response (0.02-289.2 µM), a low detection limit (0.0026 µM), and good anti-interfering ability, acclaim its superior viability for real-time detection of TP with exceptional tolerance to the presence of foreign moieties. Hence, this work manifests that the nature of intercalants is a vital aspect to consider while designing LDH-based electrochemical probes to detect priority pollutants.
RESUMEN
In the evolving field of electrocatalysis, thermal treatment of nano-electrocatalysts has become an essential strategy for performance enhancement. This review systematically investigates the impact of various thermal treatments on the catalytic potential of nano-electrocatalysts. The focus encompasses an in-depth analysis of the changes induced in structural, morphological, and compositional properties, as well as alterations in electro-active surface area, surface chemistry, and crystal defects. By providing a comprehensive comparison of commonly used thermal techniques, such as annealing, calcination, sintering, pyrolysis, hydrothermal, and solvothermal methods, this review serves as a scientific guide for selecting the right thermal technique and favorable temperature to tailor the nano-electrocatalysts for optimal electrocatalysis. The resultant modifications in catalytic activity are explored across key electrochemical reactions such as electrochemical (bio)sensing, catalytic degradation, oxygen reduction reaction, hydrogen evolution reaction, overall water splitting, fuel cells, and carbon dioxide reduction reaction. Through a detailed examination of the underlying mechanisms and synergistic effects, this review contributes to a fundamental understanding of the role of thermal treatments in enhancing electrocatalytic properties. The insights provided offer a roadmap for future research aimed at optimizing the electrocatalytic performance of nanomaterials, fostering the development of next-generation sensors and energy conversion technologies.
RESUMEN
Resolving chromatin-remodeling-linked gene expression changes at cell-type resolution is important for understanding disease states. Here we describe MAGICAL (Multiome Accessibility Gene Integration Calling and Looping), a hierarchical Bayesian approach that leverages paired single-cell RNA sequencing and single-cell transposase-accessible chromatin sequencing from different conditions to map disease-associated transcription factors, chromatin sites, and genes as regulatory circuits. By simultaneously modeling signal variation across cells and conditions in both omics data types, MAGICAL achieved high accuracy on circuit inference. We applied MAGICAL to study Staphylococcus aureus sepsis from peripheral blood mononuclear single-cell data that we generated from subjects with bloodstream infection and uninfected controls. MAGICAL identified sepsis-associated regulatory circuits predominantly in CD14 monocytes, known to be activated by bacterial sepsis. We addressed the challenging problem of distinguishing host regulatory circuit responses to methicillin-resistant and methicillin-susceptible S. aureus infections. Although differential expression analysis failed to show predictive value, MAGICAL identified epigenetic circuit biomarkers that distinguished methicillin-resistant from methicillin-susceptible S. aureus infections.
RESUMEN
Cancer is one of the most common and widely diagnosed diseases worldwide. With an increase in prevalence and incidence, many studies in cancer biology have been looking at the role pro-cancer proteins play. One of these proteins is the Really Interesting New Gene (RING), which has been studied extensively due to its structure and functions such as apoptosis, neddylation, and its role in ubiquitination. The RING domain is a cysteine-rich domain known to bind Cysteine and Histidine residues. It also binds two zinc ions that help stabilize the protein in various patterns, often with a 'cross-brace' topology. Different RING finger proteins have been studied and found to have suitable targets for developing anti-cancer therapeutics. These identified candidate proteins include Parkin, COP1, MDM2, BARD1, BRCA-1, PIRH2, c-CBL, SIAH1, RBX1 and RNF8. Inhibiting these candidate proteins provides opportunities for shutting down pathways associated with tumour development and metastasis.
RESUMEN
Acute abdominal pain, defined as nontraumatic abdominal pain lasting fewer than seven days, is a common presenting concern with a broad differential diagnosis. The most common causes are gastroenteritis and nonspecific abdominal pain, followed by cholelithiasis, urolithiasis, diverticulitis, and appendicitis. Extra-abdominal causes such as respiratory infections and abdominal wall pain should be considered. Pain location, history, and examination findings help guide the workup after ensuring hemodynamic stability. Recommended tests may include a complete blood count, C-reactive protein, hepatobiliary markers, electrolytes, creatinine, glucose, urinalysis, lipase, and pregnancy testing. Several diagnoses, such as cholecystitis, appendicitis, and mesenteric ischemia, cannot be confirmed clinically and typically require imaging. Conditions such as urolithiasis and diverticulitis may be diagnosed clinically in certain cases. Imaging studies are chosen based on the location of pain and index of suspicion for specific etiologies. Computed tomography with intravenous contrast media is often chosen for generalized abdominal pain, left upper quadrant pain, and lower abdominal pain. Ultrasonography is the study of choice for right upper quadrant pain. Point-of-care ultrasonography can aid in the prompt diagnosis of several etiologies of acute abdominal pain, including cholelithiasis, urolithiasis, and appendicitis. In patients who have female reproductive organs, diagnoses such as ectopic pregnancy, pelvic inflammatory disease, and adnexal torsion should be considered. If ultrasonography results are inconclusive in pregnant patients, magnetic resonance imaging is preferred over computed tomography when available.
Asunto(s)
Abdomen Agudo , Apendicitis , Colelitiasis , Diverticulitis , Embarazo , Humanos , Adulto , Femenino , Apendicitis/complicaciones , Apendicitis/diagnóstico , Dolor Abdominal/diagnóstico , Dolor Abdominal/etiología , Abdomen Agudo/etiología , Ultrasonografía , Diagnóstico Diferencial , Diverticulitis/diagnóstico , Enfermedad Aguda , Colelitiasis/complicaciones , Colelitiasis/diagnósticoRESUMEN
Diethofencarb (DFC) is widely used in agriculture to fight against plant fungal attacks and enhance food crop production. On the other hand, the National food safety standard has set the overall maximum residual limit of DFC to be 1 mg/kg. Hence it becomes essential to limit their usage, and it is vital to quantify the amount of DFC present in real-life samples to safeguard the health and environmental well-being. Here, we introduce a simple hydrothermal procedure for preparing vanadium carbide (VC) anchored by ZnCr-LDH. The sustainably designed electrochemical sensor for the detection of DFC portrayed high electro-active surface area, conductivity, rapid-electron transport ratio, and high ion diffusion parameters. The obtained structural and morphological information confirms the enriched electrochemical activity of the ZnCr-LDH/VC/SPCE towards DFC. The ZnCr-LDH/VC/SPCE electrode has displayed exceptional characteristics with DPV resulting in a vast linear response (0.01-228 µM), and lower LOD (2 nM) with high sensitivity. Real-sample analysis was carried out to demonstrate the specificity of the electrode with an acceptable recovery in both water (±98.75-99.70%) and tomato (±98.00-99.75%) samples.
Asunto(s)
Fungicidas Industriales , Nanocompuestos , Vanadio , Técnicas Electroquímicas/métodos , Hidróxidos/química , Nanocompuestos/química , Carbonatos , ElectrodosRESUMEN
In this work, we propose a modified solid-state approach for the sustainable preparation of a SrWO4 bifunctional catalyst using thymol-menthol-based natural deep eutectic green solvents (NADESs). Various spectroscopic and morphological techniques analyzed the as-synthesized SrWO4 particles. Acetaminophen (ATP) and metformin (MTF) were selected as the model drug compounds. The electrochemical detection and photocatalytic degradation of ATP and MTF upon ultraviolet-visible (UV-vis) light irradiation in the presence of as-prepared SrWO4 particles as an active catalyst are examined. The present study displayed that the proposed catalyst SrWO4 has enhanced catalytic activity in achieving the optimum experimental conditions, and linear ranges of ATP = 0.01-25.90 µM and MTF = 0.01-25.90 µM, a lower limit of detection (LOD) value (ATP = 0.0031 µM and MTF = 0.008 µM), and higher sensitivity toward ATP and MTF determination were obtained. Similarly, the rate constant was found to be k = ATP = 0.0082 min-1 and MTF = 0.0296 min-1 according to the Langmuir-Hinshelwood model, benefitting from the excellent synergistic impact of the SrWO4 catalyst toward the photocatalytic degradation of the drug molecule. Hence, this work offers innovative insights into the applicability of the as-prepared SrWO4 bifunctional catalyst as an excellent functional material for the remediation of emerging pollutants in water bodies with a recovery range of 98.2-99.75%.
Asunto(s)
Acetaminofén , Disolventes Eutécticos Profundos , Acetaminofén/química , Solventes , Adenosina TrifosfatoRESUMEN
Ractopamine (RA) has been at the forefront of feed additives as a nutrient repartitioning mediator that recuperates the growth rate, decreases animal fat, and guarantees food safety. However, inappropriate and abusive usage of RA to enhance economic efficiency can negatively impact the environment-animal-human interactions. Therefore, the call for monitoring and quantifying RA is highly desired. In this work, the potentiality of La2Sn2O7 as an electrode modifier on the surface of the portable screen-printed carbon electrode (SPCE) was examined for its precision, disposability, and ability to detect RA. The superior electrocatalytic activity of the fabricated La2Sn2O7/SPCE fortifies its standpoints by displaying a wide linear working range of 0.01-501.2 µM, an enhanced sensitivity, a better stability, a lower LOD of 0.86 nM, and an increased selectivity toward the detection of RA. Furthermore, the investigation of the constructed electrochemical sensor with real-time food samples underpins its practicality and feasibility.
Asunto(s)
Carbono , Lantano , Animales , Humanos , Fenetilaminas , Electrodos , Técnicas ElectroquímicasRESUMEN
DNA methylation comprises a cumulative record of lifetime exposures superimposed on genetically determined markers. Little is known about methylation dynamics in humans following an acute perturbation, such as infection. We characterized the temporal trajectory of blood epigenetic remodeling in 133 participants in a prospective study of young adults before, during, and after asymptomatic and mildly symptomatic SARS-CoV-2 infection. The differential methylation caused by asymptomatic or mildly symptomatic infections was indistinguishable. While differential gene expression largely returned to baseline levels after the virus became undetectable, some differentially methylated sites persisted for months of follow-up, with a pattern resembling autoimmune or inflammatory disease. We leveraged these responses to construct methylation-based machine learning models that distinguished samples from pre-, during-, and postinfection time periods, and quantitatively predicted the time since infection. The clinical trajectory in the young adults and in a diverse cohort with more severe outcomes was predicted by the similarity of methylation before or early after SARS-CoV-2 infection to the model-defined postinfection state. Unlike the phenomenon of trained immunity, the postacute SARS-CoV-2 epigenetic landscape we identify is antiprotective.
Asunto(s)
COVID-19 , Adulto Joven , Humanos , COVID-19/genética , SARS-CoV-2/genética , Estudios Prospectivos , Metilación de ADN/genética , Procesamiento Proteico-PostraduccionalRESUMEN
BACKGROUND: COVID-19 is associated with cardiac complications. OBJECTIVES: The purpose of this study was to estimate the prevalence, risk factors, and outcomes associated with acute cardiac events during COVID-19-associated hospitalizations among adults. METHODS: During January 2021 to November 2021, medical chart abstraction was conducted on a probability sample of adults hospitalized with laboratory-confirmed SARS-CoV-2 infection identified from 99 U.S. counties in 14 U.S. states in the COVID-19-Associated Hospitalization Surveillance Network. We calculated the prevalence of acute cardiac events (identified by International Classification of Diseases-10th Revision-Clinical Modification codes) by history of underlying cardiac disease and examined associated risk factors and disease outcomes. RESULTS: Among 8,460 adults, 11.4% (95% CI: 10.1%-12.9%) experienced an acute cardiac event during a COVID-19-associated hospitalization. Prevalence was higher among adults who had underlying cardiac disease (23.4%; 95% CI: 20.7%-26.3%) compared with those who did not (6.2%; 95% CI: 5.1%-7.6%). Acute ischemic heart disease (5.5%; 95% CI: 4.5%-6.5%) and acute heart failure (5.4%; 95% CI: 4.4%-6.6%) were the most prevalent events; 0.3% (95% CI: 0.1%-0.5%) experienced acute myocarditis or pericarditis. Risk factors varied by underlying cardiac disease status. Patients with ≥1 acute cardiac event had greater risk of intensive care unit admission (adjusted risk ratio: 1.9; 95% CI: 1.8-2.1) and in-hospital death (adjusted risk ratio: 1.7; 95% CI: 1.3-2.1) compared with those who did not. CONCLUSIONS: Acute cardiac events were common during COVID-19-associated hospitalizations, particularly among patients with underlying cardiac disease, and are associated with severe disease outcomes. Persons at greater risk for experiencing acute cardiac events during COVID-19-associated hospitalizations might benefit from more intensive clinical evaluation and monitoring during hospitalization.